MedPath

VCN-01

Generic Name
VCN-01
Drug Type
Biotech

Overview

VCN-01 is an investigational, genetically modified human adenovirus encoding human PH20.

Background

VCN-01 is an investigational, genetically modified human adenovirus encoding human PH20.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Active, not recruiting
Posted: 2021/09/27

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath